{"url_path":"/sec/cochw/8-k/2026-05-18/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 ** **Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-18","source_url":"https://www.sec.gov/Archives/edgar/data/1840877/0001213900-26-058429-index.html","accession_number":"0001213900-26-058429","cik":"0001840877","ticker":"COCH","issuer_name":"Envoy Medical, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1840877/0001213900-26-058429-index.html","primary_entity_key":"0001840877","primary_entity_name":"Envoy Medical, Inc."},"word_count":101,"has_tables":true,"body_markdown":"** **\n\n**Item 9.01** **Financial Statements and Exhibits.**\n\n \n\n(d) Exhibits.\n\n \n\n**Exhibit No.**\n \n**Description**\n\n10.1\n \n[Amended No. 1 to Envoy Medical, Inc. Amended and Restated 2023 Equity Incentive Plan](ea029135401ex10-1.htm)\n\n10.2\n \n[Amended No. 1 to Envoy Medical, Inc. 2023 Employee Stock Purchase Plan](ea029135401ex10-2.htm)\n\n104\n \nCover Page Interactive Data File (embedded with the Inline XBRL document).\n\n** **\n\n2\n\n \n\n** **\n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934,\nthe Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n**ENVOY MEDICAL, INC.**\n\n \n \n\nMay 18, 2026\nBy: \n/s/ Brent T. Lucas\n\n \n \nBrent T. Lucas\n\n \n \nChief Executive Officer\n\n \n\n3"}